← back to search

Mattias Rydenfelt

Charité - Universitätsmedizin Berlin · DE
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Gene Regulatory Network Analysis, Genomics and Chromatin Dynamics, Bacterial Genetics and Biotechnology, and RNA and protein synthesis mechanisms.
h-index
9
citations
625
works
25
NIH funding
primary concept
email

Recent publications

SPEED2: inferring upstream pathway activity from differential gene expression
Nucleic Acids Research 2020cited by 40position: firstdoi
The cancer cell proteome and transcriptome predicts sensitivity to targeted and cytotoxic drugs
Life Science Alliance 2019cited by 16position: firstdoi
Classification of gene signatures for their information value and functional redundancy
npj Systems Biology and Applications 2017cited by 64position: middledoi
Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids
The Journal of Cell Biology 2017cited by 29position: middledoi
The Transcription Factor Titration Effect Dictates Level of Gene Expression
Cell 2014cited by 288position: middledoi
Scaling of Gene Expression with Transcription-Factor Fugacity
Physical Review Letters 2014cited by 58position: middledoi
The Influence of Promoter Architectures and Regulatory Motifs on Gene Expression in Escherichia coli
PLoS ONE 2014cited by 51position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Nils Blüthgen · German Cancer Research Center4 papers (2017–2020)Rob Phillips · Massachusetts Institute of Technology3 papers (2014–2014)Robert C. Brewster · California Institute of Technology2 papers (2014–2014)Franz M. Weinert · California Institute of Technology2 papers (2014–2014)Bertram Klinger · Humboldt-Universität zu Berlin2 papers (2019–2020)Hernán G. García · Princeton University2 papers (2014–2014)Matthew Wongchenko · Genesys (United States)1 papers (2019–2019)Christine Sers · Humboldt-Universität zu Berlin1 papers (2017–2017)Markus Morkel · German Cancer Research Center1 papers (2017–2017)Matthias Marks · Freie Universität Berlin1 papers (2017–2017)Pamela Riemer · German Cancer Research Center1 papers (2017–2017) · 1 papers (2014–2014)Kathrin Thedieck · German Cancer Research Center1 papers (2017–2017) · 1 papers (2017–2017)Emmanuel Barillot · King Abdullah University of Science and Technology1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2017–2017)Laura Cantini · Institut Pasteur1 papers (2017–2017) · 1 papers (2017–2017)Bernhard G. Herrmann · Charité - Universitätsmedizin Berlin1 papers (2017–2017)